chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Right and left hip area pain.  Pain leave on lefts side 5/6 and right side 2/3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 19Feb2021 12:00 (Lot number: EL3249) at the age of 61 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EL0142, Location of injection: Arm Right, Vaccine Administration Time: 12:00 AM), administration date: 19Jan2021, for COVID-19 immunization. The following information was reported: ARTHRALGIA (non-serious) with onset May2021, outcome "not recovered", described as "Right and left hip area pain.  Pain leave on lefts side 5/6 and right side 2/3". The event "right and left hip area pain.  pain leave on lefts side 5/6 and right side 2/3" was evaluated at the physician office visit. Therapeutic measures were taken as a result of arthralgia. Additional information: known allergies no. other medical history yes. Treatment received for the adverse event: To where my back brace. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
12/16/04 PC from mother declining immunizations describes rash on chin that spread to cheeks night of vaccine administration (12/2/04). On 12/4/04: generalized rash over arms, legs or back. Some pink, some red, raised, splotchy. Denies fever, change in appetite or activity level. Saw doctor 12/4/04. Thought not vaccine related. Did lab test for allergies: was negative. 12/16/04: still with rash just peaking today. Mother deferred all immunizations until now or only wanted one given at a time.
This spontaneous report was received from a healthcare worker referring to a 4 month old patient of unknown gender. The patients' concurrent conditions and medical histories were not provided. On 23-OCT-2015, the patient was vaccinated with a dose of improperly stored ROTATEQ orally (dose was unknown, lot # K023532, expiration date 21-JUN-2016). Concomitant medication was not reported. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
patient had feelings of rapid heart rate, BP 102/69, HR70, RR14. Patient stable and discharged.
Moderna on 1/25 and 2/18. Positive on 8/13 admitted on 8/13-current
Jan 8 2021 I felt tingly all over, could literally feel it go from the left to the right side, in my ears a      In the car my uterus hurt. currently I feel heavy and my right ear and jaw kinda hurt Now pain is in my forehead. And in my jaws. Now it?s in the top of my head.  I feel like an anchor is weighing me down.   Feel it in the top of my nose  Calves are itchy with bumps  Face itchy( chin)  Belly itchy with bumps  Jan 9th  Sore left arms and same rash   Please see my updates on the app
feverish for 2-3 days, beginning 1 wk p/vax; mid-afternoon the 1st day of fever, fever shot up to 104.9 & had sz; convulsed for about 2 mins; 2 days later when fever was no longer so high, lt rash appeared on body lasted only 1 day;
This spontaneous report as received from a physician via company representative refers to a 16 month old male patient. Information regarding concomitant medications and drug reactions or allergies was not reported. On 21-AUG-2013 the patient was orally vaccinated with a first dose of ROTATEQ (oral solution, lot#: J004394, expiration date: 10-SEP-2014). On 23-OCT-2013 the patient was orally vaccinated with a second dose of ROTATEQ (oral solution, lot #: J00050 which is an invalid lot number for ROTATEQ). On 12-DEC-2013 the patient was orally vaccinated with a third dose of ROTATEQ (oral solution, lot#: J006197, expiration date not assigned and not reported). Concomitant medications were not reported. The physician reported to the company representative that "a patient experienced rotavirus after completing the ROTATEQ vaccination regimen". On 22-OCT-2014 the patient was admitted to Medical Center for 24-hour period (till approximately October 2014) with severe dehydration, where he tested positive for rotavirus ("stool specimen" testing). Two days prior to the hospitalization (in approximately 20-OCT-2014) the patient had been taken to the ER with dehydration but was sent home. There was treatment given with unspecified intravenous (IV) fluids for the events of rotavirus and dehydration. The outcome of rotavirus and dehydration was reported as recovered/resolved in approximately 2014, exact dates not reported. The outcome of rotavirus test positive was unknown. The relatedness between the therapy with ROTATEQ and the events was not reported. Additional information has been requested.
HEADACHE; This spontaneous report received from a consumer concerned a 78 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. The batch number was not provided and it has been requested.. No concomitant medications were reported. On MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine  was not applicable. The patient had not recovered from headache. This report was non-serious. This case, involving the same patient is linked to 20210520783
Per patient she developed rash all over body 2 days after receiving Fluvirin (0.5 ml) shot according to patient  rash comes and goes away everyday. 12/2/09 Medical records received for date 10/19/09. DX: urticaria/hives. Presented w/ c/o recurrent hives w/ itch.
Pt to hospital for seizures.  The patient underwent a CT scan of the head and he was found to have small volume subarachnoid hemorrhage to the left anterior frontal lobe.  He was seen by Neurology and Neurosurgery.  He was continued on seizure medications. Anticoagulation was withheld due to the subarachnoid hemorrhage.  Overall, he was doing better and was cleared for discharge from a Neurosurgery and Neurology standpoint, but he ended up testing positive for COVID-19.  He was then transferred to an isolation room and was placed in isolation.  He was not having any respiratory issues. DIscharged 1/14/22
Dizziness, syncope, headaches, blurred vision, constipation, insomnia, racing heart, chest pain 12/06 to present. Treatment: Florinef, Midrodone, Mestinon 6/7/07-records received from facility for DOS 5/10-5/15/07-Impression:orthostatic intolerance. EEG, somewhat disorganized occipital dominant rhythm. CT head unremarkable. CBC WNL. Echocardiogram normal. Tilt table test with electrophysiologic study no orthostatic hypotension with head-up tile but a prominent tachycardia. Apparent stimulation of A-V nodal pathway showed no evidence of an A-V nodal re-entrant tachycarida. HX of recurrent syncope. Onset of occasional chest pain and a fleeting sensation of palpitations. Without any other symptoms until January of this year. C/O being dizzy a lot. PE WNL except for some palmar hyperhidrosis. 6/20/07-record received fro DOS 1/9-5/29/07. One year history of significant recurrent arrhythmia with heart pounding especially when laying flat or bending forward. No syncope during exercise. Possible mitral valve prolapse.  DC DX: from 1/9-1/11/07-Orthostatic paroxysmal tachycardia. DC DX for DOS 3/15-3/20/07-Postural orthostatic tachycardia syndrome. Recurrent syncope. Orthostatic hypotension.
Diagnosed with influenza A; Spontaneous report received on 28FEB2020.   A physician (consumer's mother) reported that her 9-year-old child was diagnosed with influenza A (PT: Influenza) while being on Vivotif for immunisation. The child received first, second and third dose of Vivotif on 22FEB2020, 24FEB2020 and 26FEB2020 respectively. On 26FEB2020, the child developed symptoms and was diagnosed with influenza A on 27FEB2020. The physician stated that the fever was coming down on 28FEB2020. The child did not receive the last dose of Vivotif on 28FEB2020. Action taken with Vivotif with respect to the reported event was vaccine withdrawn. The outcome of the reported event was resolving at the time of report.  Company Comment: A consumer was diagnosed with influenza A (Influenza) a day after taking third dose of Vivotif. In response to the event, fourth dose of Vivotif was not given and the fever came down a day later. Considering the infectious pathogenesis of influenza (a viral infection), the causality of the event is assessed as unlikely with Vivotif.; Sender's Comments: A consumer was diagnosed with influenza A (Influenza) a day after taking third dose of Vivotif. In response to the event, fourth dose of Vivotif was not given and the fever came down a day later. Considering the infectious pathogenesis of influenza (a viral infection), the causality of the event is assessed as unlikely with Vivotif.
Information per RN  Well child appointment 4:30 PM 09/26/2022  Due for 4 month vaccines: Pentacel (DTaP, IPV, Hib), Prevnar, Rota  Child up to date on vaccinations according to system  RN ordered immunizations due in system w/provider as cosigner  RN prepared vaccines to be administered at 4:55 pm  RN opened new box of Pentacel (Lot:  RN took out 1 vial of DTap-IPV  RN did not take out vial of Hib to be mixed w/DTap-IPV component of combination vaccine  This RN administered DTAP-IPV component of Pentacel to patient at 5:05 pm  Pt did not receive Hib vaccine  RN went to document administration of vaccinations 5:15 pm   RN then realized she did not provide Hib component of combination vaccine to child  RN was only person in clinic  RN found the below documentation:  LPN notified 09/27/2022 8:30 AM  notified 8:45 AM  Provider notified 09/27/2022 9:30 AM  RN notified 11 AM 9/27/22 The parents were not notified  No adverse effects reported by patient's parents
Information has been received from an approximately 71 year old male consumer with no pertinent medical history of drug allergies who in September 2007, "about two months," was vaccinated with one dose of ZOSTAVAX. Concomitant drug therapy included LIPITOR. In October 2007 "about a month and a half ago," the patient experienced "a crawling sensation around eyes, mostly near eyebrow of the right eye" and " a burning on arm similar to sunburn." It was noted that the patient "told the doctor" of the events. The patient was not recovered at the time of this report. There was no product quality complaint. Additional information has been requested. Follow-up information has been received from a medical assistant indicating that a 76 year old (also reported as approximately 71 year old) retired male who on 05-SEP-2007 was vaccinated SC with a dose of ZOSTAVAX (Merck) (lot # 658081/0743U) in the left arm. On 27-AUG-2007 the patient was seen by the physician for a burning sensation on forehead. On 17-OCT-2007 the patient complained of a crawling sensation under skin. It was noted that the patient never reported connecting the symptoms with the vaccine. The patient also did not contact the physician's office about a reaction or any problems. Additional information has been requested.
No adverse effects reported; 19 year old female patient was inadvertently administered a pediatric dose of VAQTA; This spontaneous report was received from a medical assistant regarding a female patient of unknown age. The patient's concurrent conditions, pertinent medical history, drug reactions, allergies, and concomitant therapies were not reported.   On 07-OCT-2019, the patient was inadvertently administered a pediatric dose (incorrect dose administered) of Hepatitis A Vaccine, Inactivated (VAQTA) lot number S009943, expiration date 26-JUL-2020 for prophylaxis. No adverse effects reported.
While eating dinner, my lips and face around my mouth began to swell. They swelled to the point that it was very visible and became hard to enunciate due to the excessive swelling of the lips. The swelling lasted over 24 hours and did not respond to antihistamines.
Information has been received from a physician referring to unspecified patients of unknown age and gender. On unknown dates the patients were vaccinated with doses of improperly stored VARIVAX (lot# M024681 with expiration date of 20-JAN-2018, strength, dosage, frequency and route unspecified) for prophylaxis. No adverse effects were reported. It was reported that temperature was from -14 to -10 degree C and time frame was 6 hours. There was previous temperature excursion which was from -14 to -10 degree C for 30 hours.
1 1/2" swelling, mass on jaw, first noticed about noon today.  Tender to touch.  Jaw aching, but no teeth pain on percussion. Swelling is firm and hard. The pt put moist compresses on mass and the following a.m. it was nearly gone.
Flu syndrome; Pain; dizziness; fever; This is a spontaneous report from a non-contactable other healthcare professional. This reporter reported similar events for two patients. This is the first of two reports.  A 7-decade-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as unknown, single dose, for COVID-19 immunisation; atorvastatin calcium (manufacturer unknown), route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication; gabapentin (manufacturer unknown), route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication; sertraline hcl (ZOLOFT), route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication. The patient medical history was not reported. Concomitant medication included daratumumab (DARZALEX) taken for an unspecified indication, start and stop date were not reported. It was reported that patient experienced side effects from COVID vaccine and other drugs (atorvastatin, gabapentin, and ZOLOFT) of flu syndrome, pain, fever, dizziness. Patient couldn't even work. The action taken in response to the events for bnt162b2 was not applicable while for atorvastatin calcium, gabapentin and sertraline hcl was unknown. The outcome of events was unknown.  Pfizer is a marketing authorization holder of atorvastatin calcium, gabapentin in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of atorvastatin calcium, gabapentin has submitted the same report to the regulatory authorities.   No follow up attempts are possible, information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : PFIZER INC-2021494017 Same reporter and product, similar events, different patients
have even contemplated suicide; vaccine injured; my health continuing declining; You ruined my life; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SUICIDAL IDEATION (medically significant, life threatening), outcome "unknown", described as "have even contemplated suicide"; INJURY (non-serious), outcome "unknown", described as "vaccine injured"; GENERAL PHYSICAL HEALTH DETERIORATION (non-serious), outcome "unknown", described as "my health continuing declining"; IMPAIRED QUALITY OF LIFE (non-serious), outcome "unknown", described as "You ruined my life". Additional information: Reporter stated "You ruined my life I hope who ever reads this knows the suffering this company has brought me. We are the vaccine injured and we have zero support instead we are being gaslighted by the medical professionals. You knew and hid the data. I was a healthy 23m and have even contemplated suicide. Due to the lack of support and my health continuing declining. We are real not rare."  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
VERTIGO ONSET ABOUT 7PM.  ROOM WAS SPINNING AND I LOST MY BALANCE WHEN WALKING.  SYMPTOMS WORSENED WHEN LYING ON MY BACK OR RIGHT SIDE.  TOOK A BENEDRYL 10MG AND WENT TO BED.  SYMPTOMS LASTED THROUGHOUT THE NIGHT WHENEVER I MOVED AROUND.  A LITTLE BETTER IN THE MORING BUT STILL SPINNING SO TOOK DRAMAMINE.  SYMPTOMS IMPROVED THROUGHOUT THE DAY WITH JUST A LITTLE DIZZINESS BY 8:30 PM
Patient had gotten pfizer for all 3 shots so far and accidently got moderna for their 4th booster. Got 0.25mL of Moderna.
Feeling unwell; fast heart beat; nauseous; unbalanced when walking; This is a spontaneous report from a contactable consumer (patient). A 78-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN9810 and Expiration date not reported) via an unspecified route of administration, administered in Arm Left on 04Feb2021 14:35 as 1st dose single dose for COVID-19 immunisation. The patient medical history included anxiety from Unspecified to Unspecified date. The patient concomitant medication included alprazolam (XANAX) taken for anxiety from Unspecified to Unspecified date. The patient received no other vaccines in the past 4 weeks period. On 05Feb2021, morning, she noticed she is feeling unwell and had a fast heart beat. After eating it got a little better. It says on the paperwork normal side effects to expect like feeling unwell and fast heartbeat which has calm down for her, but she was wondering how long this was expected to last and have the side effect. She was not feeling good this morning. She doesn't want this to last a long time. The patient reported that after the vaccine she felt nothing, no pain, no pain even at the arm. The patient reported that, she was not completely sure how she was feeling because she was sitting now, she felt nauseous and unbalanced, she was feeling unwell. As she was sitting down, she thinks it was better, but she still feels unbalanced when walking. The patient took half a Xanax when her heartbeat was fast, that was usually the trick that slows it. It was reported that, she takes Xanax for anxiety and maybe that was it was. She took the Xanax because she had to wait on the phone for so long to speak to someone. The second dose was schedule date on 02Mar2021. The patient had so many medications, but had not taken them before this started, she took them later. The patient received list of what she could expect, on the list what she had was a common reaction, but the Fast heart rate was in the call section, but it was not that bad for her to call 911 as she knows a fast heartbeat can happen with her anxiety. She usually gets the flu vaccine and pneumonia vaccine, she does not remember when she had it last, she usually gets them when it comes out or when pharmacy announces it and asks her. The patient noticed that people who usually get the COVID virus die of Pneumonia, so she thought she would get the pneumonia vaccine. The patient had some exam 2 weeks ago, and yesterday the Physician left a message about the results and did state on the phone that she has nothing to worry about. The outcome of Feeling unwell was not resolved and fast heart beat was resolving.  Follow-up attempts are completed. No further information is expected.
On 6/8/21  the 8 year old client presented for catch up vaccination. After reviewing the clients record, it was determined by this nurse that the client had missed his 5th dose of DTaP and his 4th dose of IPV, also his second dose of both MMR and Varicella. This nurse inadvertently administered the Kinrix vaccine to the 8 year old child and Kinrix is only licensed for use in children ages 4 to 6 years old.  Due to the clients age, the child should have received 2 separate injections of Tdap and IPV. This error was caught by billing on 7/8/2021. The clients mother was notified of the vaccine error on 07/19/2021 , an incident report was completed and now  this nurse is submitting a VAERS form for  vaccine error.
Complains of right deltoid pain, apparent tenderness. Treatment take TYLENOL or MOTRIN for pain & warm compresses as needed.
Adverse neurological details: The tingling and burning (mostly burning) in my hands and feet during day and night & numbness/falling asleep of various body parts (e.g., hands, feet, face, shoulders, torso) at night, which I began to experience 87 days* after my second COVID-19 vaccine (Moderna full-dose) on 3/22/2021, came back with a vengeance 15 hours after my COVID-19 booster (Moderna half-dose) on 11/13/2021 and has continued to varying degrees ever since. (Unlike after the second vaccine dose, I did not experience dizziness after this booster.) In addition to the adverse reactions above, 15 hours after the COVID-19 booster I also had tingling and burning of my face (mostly burning, mostly around the mouth), which has continued to varying degrees ever since. Given these adverse reactions, I am reluctant to get a second booster shot.
Nausea/vomiting,  Extreme weakness,  80%. Loss of ability to communicate.   (Significant. Enough weakness. that getting up/down and using walker compromised/dangerous)  Lasted all day. Seems largely recovered next day.  2nd does was 5 month (3/16/2021).prior.
PT REPORTED RASH FROM SHOULDER TO ELBOW, SLIGHTLY ITCHY, TX'D WITH BENADRYL 25MG, RASH GONE IN 4 DAYS.
Found in prone position in crib, covered by blanket. Preliminary cause of death is SIDS as per medical examiner.
Patient received vaccine about 11:30 am on 10-31-20.  Woke up on 11-1-20 feeling extremely nauseous and with a blood pressure at 70/40. She called her physician who instructed her to try and eat and call her daughter-in-law.  About an hour and a half after eating, her blood pressure was normal again though patient felt very nauseous and weak.
fever; This is a spontaneous report received from a contactable physician via Pfizer sales representative. A patient of an unspecified age and gender received second dose of meningococcal group B RLP2086 (TRUMENBA; Suspension for injection; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for immunisation. The patient medical history and concomitant medications were not reported. It was reported that, the physician gave meningococcal group B RLP2086 to the patient with other adolescent vaccines (unspecified) and the patients had fever following immunizations on an unspecified date. The outcome of the event was reported as unknown.   No follow up attempts are needed. No further information is expected.
Rt. arm red, slightly warm to touch, area was 1 1/2 inches wide x 3 inches in length.